ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Identification of a novel GSK-3β inhibitor for Alzheimer's disease using In-Silico prediction and experiment cycling, validated in a streptozotocin-induced Alzheimer's disease mouse model.

Neha Chauhan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.